DAFNA Capital Management’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.37M | Buy |
+526,660
| New | +$1.37M | 0.38% | 49 |
|
|
2025
Q1 | – | Sell |
-158,394
| Closed | -$230K | – | 86 |
|
|
2024
Q4 | $230K | Buy |
158,394
+41,512
| +36% | +$60.2K | 0.06% | 80 |
|
|
2024
Q3 | $215K | Hold |
116,882
| – | – | 0.05% | 81 |
|
|
2024
Q2 | $117K | Hold |
116,882
| – | – | 0.03% | 83 |
|
|
2024
Q1 | $231K | Hold |
116,882
| – | – | 0.05% | 70 |
|
|
2023
Q4 | $182K | Hold |
116,882
| – | – | 0.04% | 72 |
|
|
2023
Q3 | $230K | Hold |
116,882
| – | – | 0.07% | 69 |
|
|
2023
Q2 | $372K | Hold |
116,882
| – | – | 0.1% | 63 |
|
|
2023
Q1 | $382K | Sell |
116,882
-485,169
| -81% | -$1.59M | 0.11% | 66 |
|
|
2022
Q4 | $3.03M | Buy |
602,051
+413,957
| +220% | +$2.08M | 0.85% | 35 |
|
|
2022
Q3 | $429K | Sell |
188,094
-10,000
| -5% | -$22.8K | 0.12% | 76 |
|
|
2022
Q2 | $525K | Buy |
198,094
+2,003
| +1% | +$5.31K | 0.14% | 74 |
|
|
2022
Q1 | $269K | Hold |
196,091
| – | – | 0.07% | 88 |
|
|
2021
Q4 | $622K | Buy |
+196,091
| New | +$622K | 0.16% | 77 |
|